z-logo
Premium
Effect of ethosuximide on rest tremor in the MPTP monkey model
Author(s) -
GomezMancilla Baltazar,
Latulippe JeanFrançois,
Boucher René,
Bédard Paul J.
Publication year - 1992
Publication title -
movement disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.352
H-Index - 198
eISSN - 1531-8257
pISSN - 0885-3185
DOI - 10.1002/mds.870070207
Subject(s) - ethosuximide , diltiazem , mptp , verapamil , thalamus , medicine , essential tremor , neuroscience , dopamine , calcium , psychology , dopaminergic , epilepsy , anticonvulsant
Abstract Based on the hypothesis that low‐threshold calcium conductance in the thalamus might be involved in the pathophysiology of parkinsonian tremor, ethosuximide was given chronically to a monkey previously treated with MPTP and displaying exceptionally a typical rest tremor. After 5 days of daily treatment, the tremor was reduced by 60%. Diltiazem and verapamil which act on different calcium channels had no such effect. Ethosuximide also potentiated the antitremor effect of the dopamine D 2 agonist LY‐171555.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom